JP2019506382A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019506382A5 JP2019506382A5 JP2018536167A JP2018536167A JP2019506382A5 JP 2019506382 A5 JP2019506382 A5 JP 2019506382A5 JP 2018536167 A JP2018536167 A JP 2018536167A JP 2018536167 A JP2018536167 A JP 2018536167A JP 2019506382 A5 JP2019506382 A5 JP 2019506382A5
- Authority
- JP
- Japan
- Prior art keywords
- cancer
- tautomer
- stereoisomer
- enantiomer
- solvate
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662277653P | 2016-01-12 | 2016-01-12 | |
| US62/277,653 | 2016-01-12 | ||
| PCT/US2017/013253 WO2017123809A1 (en) | 2016-01-12 | 2017-01-12 | Compounds for inhibiting cancer and virus |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2019506382A JP2019506382A (ja) | 2019-03-07 |
| JP2019506382A5 true JP2019506382A5 (enExample) | 2020-03-05 |
Family
ID=59311465
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018536167A Pending JP2019506382A (ja) | 2016-01-12 | 2017-01-12 | 癌及びウイルスを阻害するための化合物 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US10745433B2 (enExample) |
| EP (1) | EP3402800A4 (enExample) |
| JP (1) | JP2019506382A (enExample) |
| CN (1) | CN108884123A (enExample) |
| CA (1) | CA3011289A1 (enExample) |
| TW (1) | TWI638825B (enExample) |
| WO (1) | WO2017123809A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2017223491A1 (en) * | 2016-06-23 | 2017-12-28 | Health Research, Inc. | Pharmaceutical compositions with antiflaviviral activity |
| US11384114B2 (en) | 2016-12-09 | 2022-07-12 | Warsaw Orthopedic, Inc. | Polymorphic forms of an oxysterol and methods of making them |
| CN111518147A (zh) * | 2020-04-29 | 2020-08-11 | 华东理工大学 | 苯甲酰苯胺类化合物及在制备铜绿假单胞菌抑制剂的增敏剂中的应用 |
| US11767303B2 (en) | 2020-07-24 | 2023-09-26 | Health Research, Inc. | Compounds and methods for inhibiting viral replication and methods of treating and preventing flaviviral infections |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE150471C (enExample) | ||||
| DD150471A1 (de) * | 1979-07-02 | 1981-09-02 | Konrad Schwabe | Verfahren zur herstellung von 5-bromsalizyl-4'-chloranilid-0-glykosiden |
| US6555519B2 (en) * | 2000-03-30 | 2003-04-29 | Bristol-Myers Squibb Company | O-glucosylated benzamide SGLT2 inhibitors and method |
| AU2003242118B2 (en) * | 2002-06-06 | 2008-09-11 | Institute Of Medicinal Molecular Design, Inc | O-substituted hydroxyaryl derivatives |
| WO2004006906A2 (en) * | 2002-07-15 | 2004-01-22 | Combinatorx, Incorporated | Methods for the treatment of neoplasms |
| TW200529812A (en) * | 2003-12-26 | 2005-09-16 | Chugai Pharmaceutical Co Ltd | Benzamide derivatives |
| US20080161324A1 (en) * | 2006-09-14 | 2008-07-03 | Johansen Lisa M | Compositions and methods for treatment of viral diseases |
| US8211882B2 (en) * | 2008-03-08 | 2012-07-03 | Richard Delarey Wood | Glutamate receptor modulators and therapeutic agents |
| EP2699319B1 (en) | 2011-04-18 | 2017-08-09 | Max-Delbrück-Centrum für Molekulare Medizin in der Helmholtz-Gemeinschaft | Niclosamide for the treatment of cancer metastasis |
| WO2014023329A1 (en) | 2012-08-06 | 2014-02-13 | Life And Brain Gmbh | Niclosamide and its derivatives for use in the treatment of solid tumors |
| WO2014113467A1 (en) * | 2013-01-15 | 2014-07-24 | Board Of Regents, The University Of Texas System | Stat3 inhibitor |
| CN103130696B (zh) * | 2013-03-21 | 2014-06-11 | 山东大学 | 邻氨基苯甲酰胺类化合物及其制备方法与应用 |
| CN104771386A (zh) | 2014-01-10 | 2015-07-15 | 中国科学院广州生物医药与健康研究院 | 苯甲酰胺类化合物及其应用 |
-
2017
- 2017-01-12 WO PCT/US2017/013253 patent/WO2017123809A1/en not_active Ceased
- 2017-01-12 US US16/069,100 patent/US10745433B2/en active Active
- 2017-01-12 CA CA3011289A patent/CA3011289A1/en not_active Abandoned
- 2017-01-12 EP EP17738972.3A patent/EP3402800A4/en not_active Withdrawn
- 2017-01-12 CN CN201780006499.9A patent/CN108884123A/zh active Pending
- 2017-01-12 TW TW106101068A patent/TWI638825B/zh not_active IP Right Cessation
- 2017-01-12 JP JP2018536167A patent/JP2019506382A/ja active Pending